Skip to main content
Fig. 10 | Clinical Epigenetics

Fig. 10

From: The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis

Fig. 10

High expression of JMJD6 and Myc shows the worst prognosis for human mammary gland tumors. a Kaplan-Meier survival curves are shown for the high versus low expression of JMJD6 in the presence of low (left panel) or high (right panel) expression of Myc. METABRIC database (~2000 patients) was used to perform this analysis. Analysis was performed as in a for b ER-negative or c ER-positive mammary gland tumors

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us